Skip to main
IPX
IPX logo

IperionX Ltd (IPX) Stock Forecast & Price Target

IperionX Ltd (IPX) Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

IperionX Ltd is poised for significant growth, as evidenced by the increase in the multiple applied to its 2029 EBITDA estimate from 7x to 8x, reflecting ongoing progress in the company's operations. The enhancement of the EBITDA multiple indicates confidence in IperionX's ability to ramp up production and revenue, further enhancing its valuation prospects. The company's unique positioning in the titanium market, coupled with sustainable production practices and the extensive Titan Project, underscores a robust foundation for future financial performance.

Bears say

IperionX Ltd faces several operational and financial risks that contribute to a negative outlook on its stock. Key concerns include commodity price volatility, which can significantly impact profitability, along with potential permitting and construction delays that may hinder project timelines. Additionally, the company risks failing to achieve production cost targets, encountering capital overruns, or suffering from unanticipated dilutive transactions and market events, which could jeopardize its market position and financial stability.

IperionX Ltd (IPX) has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IperionX Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IperionX Ltd (IPX) Forecast

Analysts have given IperionX Ltd (IPX) a Strong Buy based on their latest research and market trends.

According to 2 analysts, IperionX Ltd (IPX) has a Strong Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $51, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $51, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IperionX Ltd (IPX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.